Palvella Therapeutics (PVLA) Change in Receivables (2014 - 2025)

Palvella Therapeutics (PVLA) reported Change in Receivables of -$29000.0 for Q4 2025, up 91.9% quarter-over-quarter from -$358000.0 in Q1 2025.

Palvella Therapeutics (PVLA) Change in Receivables (2014 - 2025) Analysis & Trends

Palvella Therapeutics (PVLA) has 4 years of Change in Receivables data on file, last reported at -$29000.0 in Q4 2025.

Change in Receivables for Q4 2025 came in at -$29000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$387000.0 (changed N/A YoY), and the FY2025 annual result was -$387000.0, changed N/A from the prior year.
Change in Receivables advanced to -$29000.0 in Q4 2025 per PVLA's latest filing, from -$358000.0 in the prior quarter.
Over five years, Change in Receivables peaked at -$29000.0 in Q4 2025 and troughed at -$358000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	22,529.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-39.80 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-4.08 Mn
10	Palvella Therapeutics	1.49 Bn	1.23 Bn	-	-

Download Data